Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
| Revenue (Most Recent Fiscal Year) | $2.07B |
| Net Income (Most Recent Fiscal Year) | $156.70M |
| PE Ratio (Current Year Earnings Estimate) | 12.80 |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.90 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 10.58 |
| Pre-Tax Margin (Trailing 12 Months) | -1.20% |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -- |
| Current Ratio (Most Recent Fiscal Quarter) | 2.54 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.68 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.12 |
| Inventory Turnover (Trailing 12 Months) | 1.42 |
| Book Value per Share (Most Recent Fiscal Quarter) | $10.66 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | $0.47 |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | -- |
| Sector | -- |
| Industry | -- |
| Common Shares Outstanding | 432.92M |
| Free Float | -- |
| Market Capitalization | $4.17B |
| Average Volume (Last 20 Days) | 397.10 |
| Beta (Past 60 Months) | 0.92 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | -- |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.08 |
| Dividend Yield (Based on Last Quarter) | 0.87% |